drugset / Trial / NCT00147654

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

NCT00147654 ↗

Phase 4 Completed 830 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).

Timeline

Start
2004-11
Primary completion
—
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamsulosin Other / unclassified 0.4 mg —
Subject Tolterodine Unknown 4 mg —

Indications